Cost Present—Cost Future

U. S. Consumer Information Center: The Consumer Information Catalog. A Catalog of Selected Federal Publications of Consumer Interest. Pueblo, Col., Summer 1977, p. 8.

U. S. Food and Drug Administration: We Want You to Know What We Know About Prescription Drugs. Washington: DHEW Publication No. (FDA)73–3011, 1973.

Brennan J. : Your prescriptions, Los Angeles Times, YOU Section, P. 23, June 14, 1977.

Annon.: Some medicines you may want to avoid, Consumer Reports, pp. 114–117, February 1971.

Annon.: Laetrile and cancer: Should the drug be banned? Newsweek, pp. 48–56, June 27, 1977.

Silverman M. : The Drugging of the Americas. Berkeley: University of California Press, 1976.

Silverman M. : Rx for tourists: Beware the foreign prescription drug, Washington Post, pp. L-1, L-8, L-9, March 13, 1977.

Burack R. : The Handbook of Prescription Drugs. New York: Pantheon Books, 1967.

Burack R. : The New Handbook of Prescription Drugs. New York: Pantheon Books, 1971.

Long J. W. : The Essential Guide to Prescription Drugs: What you Need to Know for Safe Drug Use. New York: Harper & Row, 1977.

Huff B. B. : Physicians’ Desk Reference. Oradell, NJ: Medical Economics Company, 31st edition, 1977.

American Medical Association: Medicines and How to Use Them. Chicago, 1976.

American Medical Association: Psychoactive Drugs — What they Can and Cannot Do. Chicago, 1976.

The Medicines Your Doctor Prescribes — A Guide for Consumers, Washington: Pharmaceutical Manufacturers Association, 1974.

Whittet T. D. : The viewpoint of the European experience, Drug Inf. J. 11(Special Suppl.):26S–34S, Jan. 1977.

Television program “M. D.,” Station WLIW-TV, Channel 21, Garden City, NY.

Anon.: Danger to patients: A little drug knowledge, Med. Econ. 52:13, Nov. 10, 1975.

Barclay W. R. : The medical viewpoint, Drug Inf. J. 11(Special Suppl.):7S, Jan. 1977.

Adams J. G. : The industry viewpoint, Drug Inf. J. 11(Special Suppl.):8S–10S, Jan. 1977.

Del Prato P. S. : The community pharmacist's viewpoint, Drug Inf. J. 11(Special Suppl.):15S–17S, Jan. 1977.

Reilly M. J. : The hospital pharmacist's viewpoint, Drug Inf. J. 11(Special Suppl.):21S–25S, Jan. 1977.

Onek J. : The consumer viewpoint, Drug Inf. J. 11(Special Suppl.):11S–13S, Jan. 1977.

U. S. Food and Drug Administration: Estrogens for General Use, Fed. Regist. 41(190): 43108–43123, Sept. 29, 1976.

Frederick L. D. : Hospital costs: biggest piece of the health care bill, Med. World News 18(9):49–52, 56–57, 60, May 2, 1977.

Anon.: A bitter pill for U. S. hospitals, Time, p. 32, May 2, 1977.

Stetler C. J. : Questions and Answers about the U. S. Prescription Drug Industry. Washington: Pharmaceutical Manufacturers Association, May 1977, p. 1, Question No. 3.

Griffith H. W. : Information for patient package inserts-1, Drug Inf. J. 11(Special Suppl.)35S–40S, Jan. 1977.

Fleckenstein L. : Potential distribution problems-2, Drug Inf. J. 11(Special Suppl.):49S–52S, Jan. 1977.

Weibert R. T. Fleckenstein L. Swain M. A. : Potential distribution problems-1,-2, and -3, respectively, Drug Inf. J. 11(Special Suppl.):45S–55S, Jan. 1977.

Reilly M. J. : Second opinion: The patient package insert — I love it/I hate it. They shouldn't be required for inpatients, Curr. Prescr. 24–25, March 1977.

Barofsky I. : Potential effects on the health care system-1, Drug Inf. J. 11(Special Suppl.):71S–74S, Jan. 1977.

Hirsh H. L. : Patient package insert and liabilities, Drug Ther. 2(5):21–24, 26, May 1977.

Hirsh H. L. : The medicolegal implications of the package insert, Case and Comment pp. 14–16, 18–19, Jan.-Feb. 1977.

Mills D. H. : The medical-legal viewpoint, Drug Inf. J. 11(Special Suppl.):20S–21S, Jan. 1977.

U. S. Food and Drug Administration: Labelling of prescription drugs for patient, Fed. Regist. 40(216): 52075–52076, Nov. 7, 1975.